Metraipolis › archive › dc_fd4952015e58

Risk of neutropenia associated with Sacituzumab govitecan: a systematic review combined with the FAERS database and meta-analysis — Europe PMC PMID:41601958

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41601958
DOI: 10.3389/fphar.2025.1714638
License (as archived): solo-consultazione
Archived: 2026-10-08T05:55:54.580Z
SHA-256 of the archived text: c2d22c00ad062317442a6705d3d7d903b04cbb2d16cb60a3ecf486edbfb024d9
Stable URL of this page: https://metraipolis.com/documento/dc_fd4952015e58

How to cite

Risk of neutropenia associated with Sacituzumab govitecan: a systematic review combined with the FAERS database and meta-analysis — Europe PMC PMID:41601958 — Europe PMC (en), https://europepmc.org/article/MED/41601958 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fd4952015e58 (Metraipolis archive dc_fd4952015e58, sha256 c2d22c00ad062317442a6705d3d7d903b04cbb2d16cb60a3ecf486edbfb024d9)

BibTeX

@misc{dcfd4952015e58,
  title = {Risk of neutropenia associated with Sacituzumab govitecan: a systematic review combined with the FAERS database and meta-analysis — Europe PMC PMID:41601958},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41601958},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fd4952015e58; sha256 c2d22c00ad062317442a6705d3d7d903b04cbb2d16cb60a3ecf486edbfb024d9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41601958. Agents can read the archived copy with the MCP tool read_document.